Sánchez-Hernández, J. G., Pérez-Blanco, J. S., Rebollo, N., Muñoz, F., Prieto, V., & Calvo, M. V. (2020). Biomarkers of disease activity and other factors as predictors of adalimumab pharmacokinetics in inflammatory bowel disease. European journal of pharmaceutical sciences, 150, 105369. https://doi.org/10.1016/j.ejps.2020.105369
Chicago Style (17th ed.) CitationSánchez-Hernández, José Germán, Jonás Samuel Pérez-Blanco, Noemí Rebollo, Fernando Muñoz, Vanessa Prieto, and María Victoria Calvo. "Biomarkers of Disease Activity and Other Factors as Predictors of Adalimumab Pharmacokinetics in Inflammatory Bowel Disease." European Journal of Pharmaceutical Sciences 150 (2020): 105369. https://doi.org/10.1016/j.ejps.2020.105369.
MLA (9th ed.) CitationSánchez-Hernández, José Germán, et al. "Biomarkers of Disease Activity and Other Factors as Predictors of Adalimumab Pharmacokinetics in Inflammatory Bowel Disease." European Journal of Pharmaceutical Sciences, vol. 150, 2020, p. 105369, https://doi.org/10.1016/j.ejps.2020.105369.